How FJScience thinks
Strategic clarity in a field defined by complexity.
FJScience is built around a set of principles for thinking clearly about complex strategic questions — principles shaped by years of clinical practice, drug development experience, and senior medical affairs leadership.
Clinical understanding shapes strategic judgement.
Our strategic judgement in oncology starts from understanding the disease, the treatment journey, and the practical realities of how decisions get made in clinic — and works outward from there to positioning, evidence requirements, and competitive response.
Evidence is read in context, not in isolation.
FJScience reads evidence within its full strategic context — accounting for competitive trajectory, regulatory environment, access dynamics, and the inflection points that lie ahead.
Anticipate. Don’t react.
FJScience focuses on building strategic clarity ahead of inflection points — so that when readouts, regulatory decisions, and competitive launches occur, the response is considered, prepared, and decisive.
Senior judgement, not commodity output.
FJScience focuses on what data readouts actually mean, how to position against a competitor, and what the access landscape will look like. Our perspective is grounded in clinical and development expertise — applied where it matters most.
Honest advice, even when it’s uncomfortable.
FJScience is built on the conviction that honest, independent counsel — delivered with rigour and judgement — is what creates lasting value for partnerships navigating the most consequential decisions in oncology.
Tell us about your project.
Whether you're navigating a pivotal trial decision, a competitive launch, or an emerging access challenge — let's explore it together.